1995 : Current management took over and started manufacturing of Pharma Intermediates.
 

1997 : Started manufacturing API's -launched its first drug Trimetazidine di hydrochloride (Cardiovascular drug)
 

2000 : Came with Public offering of 25% Shares. Issue was oversubscribed by 3.85 times. Set up a R&D Block to carry out Process synthesis for API's & Intermediates.
 

2005 :Hon. Finance Minister of India Shri. P Chidambaram put our company on the INDO NEXT at The Bombay Stock Exchange. Company was awarded with ISO 9001-2000 accreditation by BVQI - UKAS & BVQI - ANAB.
 

2006 :Construction of a State of the Art Formulation Unit for Oral Solid Dosages started at Dehradun (near New Delhi) Estimated Cost of the Project : US$ 8 million.
 

2007 :Commissioning of the Formulation Plant. Started supplying formulations to reputed Pharmaceutical Companies in India on Contract Manufacturing Basis.
 

2009 :Set Up and Operationlised a new business division by name SA-FORD dedicated to Toxicological Studies.
Set Up and Operationlised a State of the Art API plant (UNIT-2) at Taloja(near Mumbai) which enables us to offer a wide variety of services to our customers.